Persistent Organic Pollutants and Mechanical Discharge: Limiting the Impact of Bariatric Surgery Through Personalized Adapted Physical Activity
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · Sep 13, 2024
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how specific types of physical activity can help patients who are scheduled for bariatric surgery, a procedure to help with severe obesity. While bariatric surgery can lead to significant weight loss and improve health, it can also cause some negative effects on the body, such as the release of harmful substances called Persistent Organic Pollutants (POPs) into the bloodstream. These substances can affect metabolism and muscle function, which is why the researchers want to find out if certain types of exercise, particularly eccentric muscle strengthening, can help protect against these issues better than other forms of exercise.
To be eligible for the trial, participants should be adults aged 18 to 55 who are planning to have bariatric surgery and currently do not engage in much physical activity. They should also be using effective contraception. Participants will take part in exercise sessions designed to help maintain muscle strength and function while monitoring any effects from the surgery. It's important to know that this trial is currently recruiting participants, so if you or someone you know fits the criteria and is interested, there is an opportunity to contribute to important research in this area.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patient (18-55 years)
- • Patient scheduled for bariatric surgery
- • Patient practicing a leisure-time physical activity \< 8 hours of moderate intensity per week or \< 4 hours of high intensity per week
- • Presence of effective contraception (hormonal or mechanical)
- Exclusion Criteria:
- • Patient already involved in another experimental study
- • Pregnant (urine pregnancy test) or breast-feeding women
- • Patient in a particular situation deemed incompatible with the study by the investigator
- • Patients from outside the Alpes-Maritimes and Var departments
- • Patient having received antibiotic treatment during the 3 months preceding the first stool collection
- • Presence of a contraindication to adapted physical activity
- • Presence of a contraindication to neurostimulation
About Centre Hospitalier Universitaire De Nice
The Centre Hospitalier Universitaire (CHU) de Nice is a leading academic medical center located in Nice, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Nice is committed to enhancing patient care by conducting rigorous studies that explore new therapies and treatment modalities across various medical disciplines. With a focus on collaboration, the center integrates cutting-edge technology and interdisciplinary expertise to ensure the highest standards of research integrity and patient safety. CHU de Nice plays a vital role in the development of evidence-based medicine, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nice, , France
Patients applied
Trial Officials
Nicolas CHEVALIER, Pr
Principal Investigator
Centre Hospitalier Universitaire de Nice
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported